Pro-Dex Inc

NASDAQ PDEX

Download Data

Pro-Dex Inc EBITDA Ratio 5 year CAGR for the quarter ending March 31, 2024: -4.29%

Pro-Dex Inc EBITDA Ratio 5 year CAGR is -4.29% for the quarter ending March 31, 2024, a -6.53% change year over year. EBITDA Ratio is the ratio of EBITDA to revenue, indicating the operating profitability and efficiency of a company. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Pro-Dex Inc EBITDA Ratio for the quarter ending March 31, 2023 was 17.48%, a 33.28% change year over year.
  • Pro-Dex Inc EBITDA Ratio for the quarter ending March 31, 2022 was 13.11%, a -26.27% change year over year.
  • Pro-Dex Inc EBITDA Ratio for the quarter ending March 31, 2021 was 17.79%, a -18.51% change year over year.
  • Pro-Dex Inc EBITDA Ratio for the quarter ending March 31, 2020 was 21.83%, a 35.51% change year over year.
NASDAQ: PDEX

Pro-Dex Inc

CEO Mr. Richard Lee Van Kirk Jr.
IPO Date Aug. 18, 1995
Location United States
Headquarters 2361 McGaw Avenue, Irvine, CA, United States, 92614
Employees 145
Sector Healthcare
Industry Medical instruments & supplies
Description

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

StockViz Staff

September 19, 2024

Any question? Send us an email